Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:34 AM EDT
111.09quote price arrow up+0.50 (+0.45%)
Volume
2,295
Close
110.59quote price arrow up+3.18 (+2.96%)
Volume
4,291,600
52 week range
62.55 - 163.24
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close110.59
  • 52 Week High163.24
  • 52 Week High Date04/14/23
  • 52 Week Low62.55
  • 52 Week Low Date11/02/23

Key Stats

  • Market Cap42.343B
  • Shares Out382.88M
  • 10 Day Average Volume3.77M
  • Dividend-
  • Dividend Yield-
  • Beta1.61
  • YTD % Change11.2

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close110.59
  • 52 Week High163.24
  • 52 Week High Date04/14/23
  • 52 Week Low62.55
  • 52 Week Low Date11/02/23
  • Market Cap42.343B
  • Shares Out382.88M
  • 10 Day Average Volume3.77M
  • Dividend-
  • Dividend Yield-
  • Beta1.61
  • YTD % Change11.2

RATIOS/PROFITABILITY

  • EPS (TTM)-12.39
  • P/E (TTM)-8.93
  • Fwd P/E (NTM)-15.25
  • EBITDA (TTM)-3.617B
  • ROE (TTM)-28.59%
  • Revenue (TTM)6.848B
  • Gross Margin (TTM)31.47%
  • Net Margin (TTM)-68.84%
  • Debt To Equity (MRQ)4.15%

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

Moderna CEO on vaccines pipeline: Investing aggressively to bring important medicine to patients
VIDEO7:5107:51
Moderna CEO on vaccines pipeline: Investing aggressively to bring important medicine to patients

Profile

MORE
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the...
Noubar Afeyan Ph.D.
Non-Executive Independent Chairman of the Board, Co-Founder
Stephane Bancel
Chief Executive Officer, Director
Stephen Hoge M.D.
President
James Mock
Chief Financial Officer
Jerh Collins
Chief Technical Operations and Quality Officer
Brad Miller
Chief Information Officer
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BIIB
Biogen Inc
216.34+4.32+2.04%
ILMN
Illumina Inc
138.68+4.88+3.65%
BNTX
Biontech SE
92.97+1.27+1.38%
GRFS
Grifols SA
6.65+0.17+2.62%
CRL
Charles River Laboratories International Inc
269.37+3.93+1.48%